We're a kids cancer research foundation, started by a kid with cancer!
We draw no salaries to be sure every penny possible can go to researching the cures.

Learn more and help us Make Some Noise!

Immunotherapy treatment in childhood cancer hits a major milestone. The FDA has approved CAR-T 19 as therapy in treating Relapsed/Refractory B-Cell ALL in pediatric patients under age 25 years of age.

The Race Act became law on August 18, 2017, and gives childhood cancer equal footing on some drugs as they are developed for adult cancers. This is one of the biggest legislative equalizers the childhood cancer community has seen.

In memory of our friend Brooke Mulford, we delivered a check to Dr. Garrett Brodeur yesterday for his exciting and promising nanoparticle research.

SUBSCRIBE TO OUR NEWSLETTER